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Dietary and Intraperitoneal Administration of Selenium Provide
Comparable Protection in the 6-Hydroxydopamine Lesion Rat
Model of Parkinson’s Disease
Sarah Mueller, Melissa Drost and Cecilia M. Fox
Moravian College, Department of Biology, Bethlehem, Pennsylvania 18018
Significant  research  implicates  the  involvement  of  free  radicals  in  the  manifestation  of
Parkinson’s disease.  The antioxidant, selenium is a vital dietary component for mammals.  It is
present in the active center of glutathione peroxidase, an antioxidant enzyme that scavenges
peroxides and protects membrane lipids and macromolecules from oxidative insult.  The purpose
of this research was to determine an effective means of delivering selenium as well as an
appropriate time frame for antioxidant administration that would elicit a protective response in
rats challenged with an intranigral 6-hydroxydopamine (6-OHDA) lesion. In the first part of this
study, Fischer 344 rats were placed into one of four groups: selenium enhanced diet, control diet,
intraperitoneal injection of selenium as Na2SeO3 or intraperitoneal injection of distilled water.
All treatments were delivered prior to an intranigral 6-OHDA lesion.  Animals were euthanized
two  weeks  post  lesion  and  their  brains  processed  for  tyrosine  hydroxylase  (TH)
immunocytochemistry. Average dopamine neuron survival in the substantia nigra of control
animals was less than 22%; whereas nigral dopamine neuron survival in the selenium fed group
was 49.7% and 56.0% in the selenium injected group. Based on these results, a subsequent study
was designed utilizing the selenium enhanced diet method of antioxidant administration.  To
examine the neuroprotective effect of long-term selenium treatment, pregnant Fischer 344 rats
were exposed to either selenium enhanced or control rat chow. Their pups were treated with the
same diet as their mothers and lesioned with 6-OHDA at two months of age.  Animals were
euthanized and their brains were processed for TH immunocytochemistry. Nigral dopamine
neuron survival for the selenium treated animals was significantly protective (59%) when
compared to the control chow fed animals (29.6%).  However, when compared to the short-term
exposure of selenium rat chow in the previous study, there was no significant increase in
neuroprotection.
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Introduction
Several  neuroprotective  strategies  in
animal models of Parkinson’s disease are based
on the hypothesis that free radicals derived from
oxidation  reactions  contribute  to  the
pathogenesis  of  this  disease  (Olanow,  1992,
Jenner et al., 1992, Lev et al., 2003, Ebadi et al.,
1996). These free radicals are highly reactive
oxygen species capable of damaging a variety of
essential biological molecules such as nucleic
acids,  membrane  lipids  and  proteins.   The
substantia nigra of the midbrain is known to be
particularly susceptible to free radical damage
due  to  its  high  levels  of  iron  and  dopamine
metabolism with the subsequent production of
hydrogen peroxide. Hydrogen peroxide is not a
free radical itself, but can generate the leading
agent  responsible  for  oxygen  toxicity  in  the
brain known as the hydroxyl radical (Gutteridge
and Halliwell, 1996, Olanow, 1993).
As a natural protective mechanism, the
brain contains antioxidant mechanisms capable
of  discontinuing  the  chain  reaction  of  free
radical formation.   Antioxidants may donate an
electron to the free radical, but are not convertedPage 2 of 10
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to free radicals themselves because they have the
ability to remain stable and unreactive in their
oxidized  form  (Halliwell,  1991).   They  also
stabilize transition metals by binding to them
and  preventing  the  donation  of  an  unpaired
electron;  thereby  inhibiting  the  reactions
responsible  for  generating  free  radicals
(Halliwell,  1991,  Daniel  et  al.,  2004).
Antioxidants known as free radical scavenging
enzymes  such  as  superoxide  dismutase,
catalyzes the alteration of the superoxide radical
to hydrogen peroxide. Glutathione peroxidase
and  catalase  consequently  scavenge  hydrogen
peroxide  to  prevent  its  conversion  into  the
hydroxyl  radical  (Olanow,  1992).    Under
normal  physiological  conditions,  a  balance
exists  between  free  radical  formation  and
antioxidant  reactivity.    Once  a  discrepancy
favoring the formation of free radicals occurs,
neurons  experience  oxidative  stress  and
subsequent  degeneration.   Based  on  this
premise,  it  is  reasonable  to  postulate  that
antioxidant therapy may offer protection against
free radical damage within neurons and reduce
the progression of disorders such as Parkinson’s
disease.
The  antioxidant,  selenium  (Se)  is  an
essential dietary component for mammals.  It is
present  in  the  active  center  of  glutathione
peroxidase  which  scavenges  peroxides  and
protects membrane lipids and macromolecules
from oxidative damage (Chen and Berry, 2003).
Recently, this antioxidant has been shown to be
effective  in  diminishing  oxidative  stress  in
several  animal  models  of  neurodegeneration.
Santamaria  et  al  (2003)  reported  that
intraperitoneal  injections  of  sodium  selenite
(0.625 mg/kg) for five days decreased the lipid
peroxidation  and  increased  the  glutathione
peroxidase activity in rats challenged with the
excitotoxin, quinolinic acid.   Kim et al (2000)
reported  that  a  ninety  day  dietary  selenium
regimen  (0.2  ppm  Se)  decreased
methamphetamine  neurotoxicity  utilizing  a
glutathione  peroxidase  mediated  antioxidant
approach  in  C57BL/6J  mice.   When
administered  in  the  form  of  sodium  selenite
(0.5mg Se/kg) in drinking water for one week,
this  antioxidant  prevented  the  depletion  of
dopamine  and  its  metabolites  resulting  from
methamphetamine  induced  neurotoxicity  in
C57Bl/6N  mice  (Imam  et  al.,  1999).   When
further examining the scope of its protection in
the dopamine system, rats deficient in selenium
displayed greater oxidative damage of dopamine
neurons following 1-methyl-4-phenylpyridinium
(MPP+) toxicity than those animals deficient in
vitamin E (Vizuete et al., 1994).   Zafar et al
(2003)  also  demonstrated  that  rats  pretreated
with  sodium  selenite  (ranging  from  0.1-0.3
mg/kg)  for  seven  days  displayed  a  dose
dependent  decrease  in  the  loss  of  dopamine
neurons in the substantia nigra and improved
behavior  function  in  animals  exposed  to  an
intrastriatal  6-hydroxydopamine  (6-OHDA)
lesion.
The  present  study  was  designed  to
further examine the ability of selenium to protect
dopamine neurons challenged with 6-OHDA.  In
this project, 6-OHDA was directly administered
into the substantia nigra rather than its target, the
striatum.  Once the cell bodies of the dopamine
neurons  residing  in  the  substantia  nigra  are
exposed  to  the  neurotoxin,  cell  death  begins
within  five  minutes  of  exposure  via  an  auto-
oxidative  process.   6-OHDA  is  a  selective
catecholamine  neurotoxin  responsible  for  the
alkylation  of  DNA  and  impairment  of
mitochondrial ATP production within substantia
nigra dopamine neurons (Sachs and Jonsson,
1975). Using this animal model of Parkinson’s
disease, two methods of selenium administration
were examined in the first part of this study.
Fischer 344 rats treated with either a three week
daily  administration  of  dietary  selenium  or  a
seven-day daily administration of selenium as
selenium  selenite  through  intraperitoneal
injection prior to an intranigral 6-OHDA lesion
displayed  significant  protection  of  dopamine
neurons within the substantia nigra.   Since the
diet form of selenium   administration was less
stressful for the animals, a subsequent study was
designed to examine the long term effects of
selenium  pretreatment  in  animals  challenged
with  6-OHDA.   In  this  second  part  of  the
project, pregnant Fischer 344 rats were exposed
to the selenium enhanced rat chow. Their pups
were treated with the same diet and exposed to
an intranigral 6-OHDA lesion at two months of
age. Nigral dopamine neuron survival for the
selenium  treated  animals  was  significantlyPage 3 of 10
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protective when compared to the control chow
fed animals.   However, when compared to the
short-term exposure of selenium rat chow in the
previous study, there was no significant increase
in neuroprotection.
Materials and Methods
Animals
For  part  one  of  this  study,  thirty-two
young  adult  male  Fischer  344  rats  (Charles
River  Laboratory)  weighing  200-250g  at  the
start of the experiment were used. The animals
were  housed  one  per  cage  in  a  temperature-
controlled (70
oF) room with a 12 hour light/ 12
hour dark cycle. The rats were randomly divided
into the following four groups: 1) selenium diet;
2) control diet; 3) selenium injected; 4) control
injected.   All  animals  were  lesioned  with  6-
OHDA three weeks post treatment.
For  the  second  part  of  the  study,  six
pregnant  Fischer  344  rats  (Charles  River
Laboratory)  were  evenly  divided  into  the
following two groups: 1) selenium diet or 2)
control diet.  They gave birth to twenty-two rat
pups (eleven in each group).   Once the pups
were weaned, they were housed one per cage in
a temperature controlled (70
oF) room with a 12
hour light/12 hour dark cycle.  The rat pups were
lesioned with 6-OHDA two months later.   The
prelesioned selenium administration period was
longer in this second study to allow the pups to
mature to young  adulthood  prior to 6-OHDA
exposure.   Selenium  treatment  was  started  in
utero to develop a model of lifelong antioxidant
enhanced  therapy.   Students  were  directly
supervised  and  trained  in  animal  handling,
surgery and euthanasia by Dr. Cecilia Fox.  The
animals  used  in  this  project  were  maintained
according to the NIH Guide for the Care and
Use of Laboratory Animals.   All protocols for
animal care and use at Moravian College are
approved by its Institutional Animal Care and
Use Committee.
Diet
Control  rat  chow  (AIN-93G  Purified
Rodent Diet) and selenium enhanced rat chow
(AIN-93  Purified  Rodent  Diet  with  2ppm
selenium)  were  purchased  from  Dyets,  Inc.
(Bethlehem, PA).  For part one of the study, the
diet treated animals received either control rat
chow or selenium enhanced rat chow for three
weeks ad libitum prior to 6-OHDA exposure.
For the second part of the study, three
pregnant  females  ingested  the  selenium
enhanced rat chow ad libitum while the three
remaining pregnant females ingested the control
rat chow ad libitum.  Each group gave birth to a
total of eleven rat pups.  The females remained
on their diet until the pups were weaned.   The
pups were then placed on the same diet as their
mothers for two months.
Intraperitoneal Injections
In  part  one  of  this  study,  selenium
through injection was administered daily as a
dose of selenium selenite (Sigma - 0.5mg/kg per
day,  i.p.)  dissolved  in  distilled  water  for  a
duration.   of  seven  days.  Control  animals
received  a  daily  injection  of  distilled  water
during the same time period.
Drugs
6-Hydroxydopamine  (6-OHDA)  was
dissolved in 0.9% saline at a concentration of
4mg/mL (Sigma).
Surgery
To  lesion  the  animals  with  6-OHDA,
they were anesthetized with sodium thiopenthal
(50mg/kg,  i.p;  Butler,  Columbus,  OH)  and
placed in a stereotaxic frame with the tooth bar
set at- 3.3mm. The skull was exposed, and a burr
hole was made using a high-speed Dremel drill.
Each  injection  of  6-OHDA  was
administered directly into the right substantia
nigra  using  the  following  coordinates:  AP  -
5.4mm;  ML  -2.2mm;  and  DV,  -8.2mm  from
skull  (Paxinos  and  Watson,  1986).  Both
selenium treated and control groups received a
single  intranigral  injection  of  this  neurotoxin
(8µg in 2µL of saline containing 0.02% ascorbic
acid).
All injections were performed using a
Hamilton 10µL syringe with a 26 gauge tapered
needle at a rate of 0.4 µL/min. At the completion
of each injection, the needle was left in place for
five minutes and then withdrawn at a rate of 2Page 4 of 10
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Figure 1. Percent neuronal survival in the substantia nigra and ventral tegmental area for selenium fed and control fed
groups. Values are represented as the means+/- S.E.M..  * P<0.05, significantly different from the control group.
mm/min.  All  surgeries  were  performed  under
aseptic conditions.
All  animals  surviving  the  surgical
procedure and post surgery care were euthanized
two weeks post lesion by intracardiac perfusion
in the first part of the study and two months post
lesion in the second part.
Tissue Preparation for Immunocyto-
chemistry
Brains  were  fixed  with  4%
paraformaldehyde solution in 50mM potassium
phosphate-buffered saline (KPBS). The brains
were then transferred to 30% sucrose in 50mM
KPBS at 4°C. Serial coronal frozen sections of
20µm  thickness  were  cut  on  a  sliding
microtome. Six sets of sections were collected in
cryoprotectant  solution  (100mM  KPBS,  30%
sucrose,  polyvinylpyrrolidone  {PVP-40}  and
30% ethylene glycol) and stored at 20°C until
immunocytochemical processing.
A series using every sixth section was
stained  for  the  primary  antibody  against  TH
(1:1000;  Chemicon,  Temecula,  CA).  Sections
exposed to the primary anti-TH antibodies were
incubated  in  biotinylated  horse  anti-mouse
secondary antibody (1:500; Vector, Burlingame,
CA). Sections were then incubated in the avidin-
biotin peroxidase complex using the Elite ABC
Vectastain  kit  (Vector,  Burlingame,  CA).  TH
immunoreactivity (TH-IR) was visualized using
3,3’-diaminobenzidine  as  the chromagen with
nickel enhancement.
Cell Counting
The number of TH positive substantia
nigra  (SN)  and  ventral  tegmental area (VTA)
neurons were counted from the brain tissue of all
experimental animals.   The counts occurred in
the SN and VTA of every sixth section between
levels  -5.3mm  and  -5.5mm  with  respect  to
Bregma.   The criterion for delineating the SN
from  the  VTA  was  the  localization  of  the
oculomoter nerve root. The VTA is medial to the
root whereas the SN is laterally located.   The
degree  of  dopamine  neuron  depletion  was
determined by the loss of TH-IR SN neurons on
the lesioned side with respect to the control side
of the brain.  Images of the substantia nigra were
captured using an Olympus DP12 Microscope
Digital Camera System.
Statistical Analysis
The experimental data were statistically
analyzed  by  means  of  analysis  of  variance
(ANOVA)  for  the  first  part  of  the  study  and
unpaired t-test for the second part.   Results are
provided as the mean +/- S.E.M.Page 5 of 10
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Results
In  the  first  part  of  this  study,  when
substantia  nigra  neurons  of  the  selenium  fed
animals were compared to those of the control
fed group, results indicated that the selenium
treatment provided some protection against 6-
OHDA neurotoxicity (p value <0.05). Average
dopamine neuron survival in the substantia nigra
for the selenium fed group was 49.7% compared
to an average of 19.0% survival for the control
fed group (Figure 1).  
Comparison of substantia nigra neuron
survival between animals administered selenium
through  intraperitoneal  injection  and  animals
treated with intraperitoneal injections of distilled
water,  also  showed  some  protection  (p  value
<0.05). Average percent survival of substantia
nigra  dopamine  neurons  for  the  selenium
injected  group  was  56.0%  compared  to  an
average  of  21.3%  survival  for  the  control
injected group (Figure 2).
When  comparing  the  methods  of
selenium  administration,  results  were  not
significantly different between the two groups.
Selenium  delivery  through  diet  yielded  a
protective value of 49.7% for substantia nigra
dopamine  neurons  while  selenium  delivered
through  intraperitoneal  injection  yielded  a
protective value of 56.0%.
Although  the  area  of  interest  in  this
study is the substantia nigra, dopamine neurons
in the ventral tegmental area were also examined
primarily  to  determine  the  extent  of  the  6-
OHDA lesion.  Neurons in the ventral tegmental
area  were  not  affected  by  the  6-OHDA
administered into the substantia nigra suggesting
that  the  toxin  was  well  localized  within  the
target area (Figures 1 and 2).
Based  on  the  results  of  this  earlier
experiment, selenium administration through a
supplemented rat chow was employed for the
second  part  of  this  study  to  minimize  the
discomfort of the selenium delivery process in
the experimental animals.   A longer period of
dietary  selenium  exposure  significantly  (p  <
0.01)  protected  dopamine  neurons  in  the
substantia nigra against 6-OHDA neurotoxicity
(Figure 3).  In the control treated animals, loss of
nigral  dopamine  neurons  appeared  to  be
extensive  (Figure  3B).   Macrophages  were
evident  in  the  needle  tracts  leading  to  the
injection site.  Damage to the substantia nigra in
the selenium treated animals appeared to be less
severe  than  observed  in  the  control  group
(Figure 3D).
Figure 2. Percent neuronal survival in the substantia nigra and ventral tegmental area for selenium injected and control
injected groups. Values are represented as the means +/- S.E.M.   * P <0.05, significantly different from the control group.Page 6 of 10
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The  average  percent  survival  of
substantia  nigra  dopamine  neurons  in  the
selenium  fed  group  was  58.8%,  while  the
average  percent  survival  of  nigral dopamine
neurons in those animals exposed to control rat
chow was 29.6% (Figure 4).  These findings are
consistent with the preceding experiment, which
also demonstrated the protective properties of
selenium supplementation.  However, there was
no  significant  improvement  in  the  protective
effect elicited by long-term selenium treatment
(58.8% survival) when compared to the short-
term selenium exposure (49.7% survival) in the
first  part  of  the  study.
Figure 3.   Representative sections are shown through the midbrain of animals in both the control and selenium treated
groups from the first part of the study.  Figures 3A and B correspond to the unlesioned side (A) and 6-OHDA lesioned side
(B) of the control group while figures 3C and 3D represent unlesioned side and 6-OHDA lesioned side of the selenium
treated animals, respectively.   There is significant sparing of substantia nigra neurons on the lesioned side of the brain in the
selenium treated animals.
Figure 4.  Percent survival of dopamine neurons in the substantia nigra of selenium and control treated animals. Values are
represented as the means +/- S.E.M. *P value<0.01.Page 7 of 10
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Once again, the ventral tegmental area
in  all  selenium  treated  and  control  animals
remained unaffected, suggesting that the toxin
was well localized within the substantia nigra
(Figure 5).
Discussion
Once free radicals were hypothesized to
contribute  to  the  pathogenesis  of  several
neurological  diseases,  an  increasing  body  of
research  has  focused  on  attempting  to
understand  the  mechanisms  behind  the
protection offered by antioxidants.  Selenium, an
essential  dietary  element,  has  recently  been
shown to have antioxidant properties due to its
localization  within  the  active  center  of
glutathione peroxidase (Schweizer et al., 2004).
As  mentioned  earlier,  the  neuroprotectant
properties of selenium have been demonstrated
against  MPP+,  quinolinic  acid,
methamphetamine  and  intrastriatal  6-OHDA
(Vizuete et al., 1994, Santamaria et al., 2003,
Imam et al., 1999, Kim et al., 1999 and Zafar et
al.,  2003).   The  results  of  our  study  provide
further evidence that the antioxidant, selenium is
capable of protecting substantia nigra dopamine
neurons against the free radical damage imposed
by 6-OHDA when administered directly into the
substantia nigra.
The selective effects of 6-OHDA in the
rat  midbrain  are  a  result  of  its  structural
similarity  to  dopamine  and  its  ability  to
efficiently  bind  to  the  high  affinity  transport
system  present  on  dopamine  cell  bodies  and
axon terminals. Since it is highly electroactive,
6-OHDA  undergoes  a  rapid  auto-oxidative
process  to  form  hydrogen  peroxide,  the
superoxide  radical  and  the  hydroxyl  radical
(Sachs and Jonnson, 1975).   When 6-OHDA is
administered directly into the substantia nigra,
the  result  is  immediate  and  almost  complete
destruction  of  dopamine  neurons  (Ungerstedt
and  Arbuthnott,  1970).   Extensive  loss  of
substantia  nigra  dopamine  neurons  is  evident
within one week of the lesion.  In contrast to the
nigral lesion which produces a model for end-
stage  Parkinson’s  disease,  the  striatal  lesion
creates a neuronal degeneration similar to the
progressive  type  of  cell  death  observed
throughout  the  course  of  this  disease.   The
chronic  loss  of  dopamine  neurons  in  the
substantia nigra due to 6-OHDA exposure is first
reported at two weeks post lesion and continues
to sixteen weeks (Sauer and Oertel, 1994).  For
the purpose of this study, the nigral lesion model
was adopted to investigate the effectiveness of
selenium in preventing the development of the
end-stage model of Parkinson’s disease.
The first part of our study was primarily
designed to determine an optimal method for
Figure 5. Percent survival of dopamine neurons in the ventral tegmental area of selenium and control treated animals. Values
are represented as the means +/- S.E.M.Page 8 of 10
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administering  selenium  to  our  experimental
animals  challenged  with  a  6-OHDA  nigral
lesion.    In our short term study, selenium was
significantly  effective  in  protecting  dopamine
neurons  of  the  substantia  nigra  when
administered  either  through  diet  (49.7%
survival)  or  intraperitoneal  injection  (56%
survival) prior to an intranigral 6-OHDA lesion.
In fact, the percent survival of nigral dopamine
neurons following both types of treatment did
not display any statistical difference.
Based  on  these  results,  a  subsequent
long  term  study  was  designed  to  examine
whether prolonged exposure to dietary selenium
could  offer  a  more  robust  protective  effect.
However, the timeline of selenium exposure in
our experimental animals needed to be carefully
considered.   Selenium  first  appeared  as  a
poisonous element in stock animals in the early
1930’s. Those animals exposed to large amounts
of  selenium  developed  two  diseases  from
selenosis now known as alkali disease and blind
staggers (Himeno and Imura, 2002).  Rats fed a
diet containing over 6ppm selenium (as sodium
selenite) for six weeks developed cirrhosis of the
liver, enlargement of the spleen and a depression
in growth rate.  It has also been shown that rats
fed  a  diet  containing  4ppm  selenium  died
months earlier than their control fed counterparts
(Himeno and Imura, 2002).   At this time, the
mechanism of selenium toxicity remains to be
completely understood.   It has been proposed
that selenite, the more toxic form of selenium, is
capable  of  inhibiting  both  DNA  and  RNA
synthesis  as  well  as  stimulating  apoptosis  in
several  cell  lines  including  premalignant  and
malignant  cells  (Himeno  and  Imura,  2002).
Therefore, depending on dosage, there appears
to  be  a  dual  role  for  selenium  as  a
neuroprotectant and toxic agent.
In  considering  the  protective  studies
already published, as well as the physiological
role of selenium, the experimental animals in the
long term study were administered selenium as
2ppm  sodium  selenite  in  rat  chow  for  two
months  prior  to  6-OHDA  exposure.   So  far,
there are no studies examining the effects of in
utero  selenium  exposure  on  development.
However, all animals appeared healthy at the
time  of  the  lesion.   When  the  animals  were
euthanized two weeks post surgery, all tissues
appeared normal.  The long term exposure from
in  utero  through  young  adulthood  conveyed
similar protection (58.8% survival) against 6-
OHDA neurotoxicity as observed in the previous
short  term  study.   There  was  no  significant
increase  in  neuroprotection  by  extending  the
treatment period.
It  is  hypothesized  that  this  increased
exposure to selenium enhances the activity of
the free radical scavenging enzyme, glutathione
peroxidase thereby preventing the conversion of
hydrogen  peroxide  into  the  hydroxyl  radical
(Vizuete et al., 1994, Santamaria et al., 2003,
Imam et al., 1999, Kim et al., 1999 and Zafar et
al.,  2003).   It  has  also  been  reported  that
following  ingestion,  selenium  is  incorporated
into  selenoproteins  as  selenocysteine  (Brauer
and Savaskan, 2004).  In fact, all selenoproteins
with enzymatic functions contain selenocysteine
at their catalytic center (Schweizer et al., 2004).
In  addition  to  glutathione  peroxidase,
glutathione  peroxidase  isoenzymes  and
thioredoxin reductases containing selenocysteine
are involved in redox defense mechanisms or
cellular  regulation  through  their  activation  of
specific  transcription  factors  (Mustacich  and
Powis,  2000).   Based  on  this  rationale,  the
greater percent survival of dopamine neurons in
the  substantia nigra observed in our selenium
supplemented animals leads us to conclude that
selenium exposure may have led to an increase
in antioxidant levels in those specially treated
animals.  Therefore, this increase in antioxidant
levels  may  have  offered  the  neurons  in  the
substantia  nigra  significantly  more  protection
against  6-OHDA  neurotoxicity  than  those
neurons of the control-fed animals.
Dopamine itself is known to contribute
to  neurotoxicity  in  the  brain.   Its  ability  to
spontaneously auto-oxidize to generate harmful
quinones and hydrogen peroxide has added to
the vulnerability of the substantia nigra.   The
addition of hydrogen peroxide to the high levels
of iron already present within this area of the
midbrain  stimulates  the  development  of
hydroxyl  radicals  via  the  Fenton  reaction
(Romeros-Ramos  et  al.,  2000).   It  has  been
hypothesized that the neuroprotection offered by
selenium  supplementation  may  be  due  to  its
ability to reduce the auto-oxidation of dopamine
by  enhancing  the  activity  of  free  radicalPage 9 of 10
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scavenging  enzymes  such  as  glutathione
peroxidase (Zafar et al., 2003).  In the presence
of 6-OHDA, the subsequent lipid peroxidation,
DNA  damage  and  impairment  of  calcium
homeostasis  may  be  the  result  of  weakened
antioxidant enzymatic activity.   However, in a
study published by An et al. (1992) selenium
was also shown to serve as a calcium channel
antagonist  in  vitro  thereby  preventing  the
unregulated  influx  of  calcium  known  to
contribute to neuronal degeneration.
The  short  term  study  revealed  a
protective  response  of  dopamine  neurons  to
selenium  when  animals  were  fed  a  selenium
enhanced diet for three weeks at a daily dose of
2ppm  selenium.   However,  no  significant
increase in protection was observed following a
selenium exposure period beginning in utero and
continuing  through  young  adulthood  utilizing
the same daily dose of selenium.   Zafar et al.
reported  a  dose  dependent  increase  in  the
antioxidant  status  and  behavioral  recovery  of
intrastriatal 6-OHDA lesioned animals exposed
to increasing doses of selenium. Perhaps in our
study, the amount of selenium administered in
the  rat  chow  was  sufficient  to  initiate  a
protective response by partially up regulating the
activity of glutathione peroxidase, but a higher
dose could have generated a more robust effect.
Although  the  use  of  selenium  as  a
neuroprotectant  is  relatively  new,  there  is
compelling  evidence  that  it  may  serve  as  a
preventive  and  therapeutic  agent  within  the
brain.  Further research targeting the underlying
mechanisms contributing to the neuroprotective
properties  of  this  element  as  well  as  the
behavioral improvements observed is needed to
clarify its role.  Future studies from our lab will
continue to investigate a safe and appropriate
dosage  of  selenium  to  administer  to  our
experimental animals as a neuroprotective agent
against  6-OHDA  neurotoxicity.   Since
functional recovery is an essential outcome of
this research, rotation behavior experiments will
be  conducted  to  determine  whether  selenium
exposure has the ability to improve the motor
function of animals exposed to an intranigral 6-
OHDA lesion.
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